Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the treatment of primary biliary cholangitis ...
FDA approves an expanded access program that would offer patients an alternative to Merck’s bladder cancer medication.
The global Embolic Protection Devices Market is valued at $601 million in 2023 and is projected to reach $1,250 million by ...
Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu SHELTON, CT / ACCESS Newswire / Febru ...
One of Trump’s biggest complaints was that the agency was too slow to alert the world of an emerging health threat in China ...
Basel: Roche, announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an ...
New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
Global Medical Adhesive Market size is expected to be worth around USD 20.9 Bn by 2032 from USD 11.3 Bn in 2023, growing at a CAGR of 7.3% Boasting a robust healthcare industry, technological ...
Roche’s Evrysdi tablet receives US FDA approval for the treatment of spinal muscular atrophy: Basel Friday, February 14, 2025, 13:00 Hrs [IST] Roche, announced that the US Food ...
FDA proposes draft guidelines on AI use in drug development, addressing challenges and opportunities for improving safety and ...